Clik here to view.
Abiomed gains after Abbott tables HeartMate PHP program
Abiomed (NSDQ:ABMD) shares closed up more than 5% yesterday as investors reacted to reports that Abbott (NYSE:ABT) paused its HeartMate PHP program in Europe. Abbott, which acquired the Thoratec line...
View ArticleClik here to view.
7 medical device industry suppliers you need to visit at MD&M West 2017
More than 20,000 engineers and executives are heading to Anaheim, Calif., this week for MD&M West—which its creator UBM bills as the world’s largest annual medical device manufacturing event. The...
View ArticleClik here to view.
Johnson & Johnson’s Mentor sued over silicone breast implants
Johnson & Johnson (NYSE:JNJ) subsidiary Mentor Worldwide’s silicone breast implants are accused of causing muscle pain, nausea and other symptoms in a product liability lawsuit reportedly filed in...
View ArticleClik here to view.
Carmat rescinds bid to resume artificial heart trial
Carmat (FRA:CXT) said yesterday that it won’t seek to resume implantations of its artificial heart after all, after French regulators suspended a clinical trial last fall after the 5th death in the...
View ArticleClik here to view.
Former Bio-Rad GC Wadler wins $11m in retaliatory firing suit
A federal jury in California yesterday reportedly awarded the former general counsel for Bio-Rad Laboratories (NYSE:BIO), Sanford Wadler, nearly $11 million in a whistleblower retaliation lawsuit...
View ArticleClik here to view.
Revisions to the common rule
U.S. federal regulations governing the protection of human subjects in research have been in existence for more than 30 years. The Department of Health, Education, and Welfare first published...
View ArticleClik here to view.
Stryker lands $486m DoD ortho supply contract
Stryker (NYSE:SYK) won a $486.3 million fixed-price contract with the US Department of Defense to supply the group with orthopedic products, according to a DoD release. The fixed-price indefinite...
View ArticleClik here to view.
Medtech approvals: FDA releases January 2017 PMA approvals
Summary of PMA Originals & Supplements Approved Originals: 4 Supplements: 40 Submission Number Date Final Decision Review Track Trade Name Appl/Spr Name Approval Order Statement P140033 01/31/2017...
View ArticleClik here to view.
Researchers develop nanoparticle delivery system for gene editing tool
Researchers from the University of Massachusetts Amherst have designed a nanoparticle delivery system to assist the gene-editing tool known as CRISPR/Cas9 across the cell membrane and into the cell...
View ArticleClik here to view.
Valeritas rekindles IPO plans, aims for $50m
Valeritas yesterday rekindled its plans for an initial public offering, but scaled its ambitions back by some $25 million. Bridgewater, N.J.-based Valeritas makes the V-Go basal insulin delivery system...
View ArticleClik here to view.
Pulmatrix updates on $3m offering
Pulmatrix (NSDQ:PULM) today updated pricing on an upcoming $3.3 million offering, looking to float 950,000 shares at $3.50 per share. The company said it expects to collect $3.1 million after paying...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for February 7, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Cardinal Health shares rise on Q2 EPS beat
Shares in Cardinal Health (NYSE:CAH) rose today after the medical device maker topped earnings per share expectations on Wall Street with its 2nd quarter results. The Dublin, Ohio-based company posted...
View ArticleClik here to view.
Non-invasive brain stimulation proven to improve memory
[Photo from unsplash.com]Scientists at Northwestern University have successfully used a non-invasive brain stimulation for the first time that can be used like a scalpel to make specific improvements...
View ArticleClik here to view.
Teva Pharma CEO Vigodman steps down | Personnel Moves, February 7, 2017
Teva Pharmaceuticals (NYSE:TEVA) said this week that CEO Erez Vigodman has stepped down from their position at the head of the world’s biggest generic drugmaker. Vigodman’s exit from the company will...
View ArticleClik here to view.
FDA accepts Flexion’s NDA for osteoarthritis steroid injection
Flexion Therapeutics (NSDQ:FLXN) said today that the FDA accepted its New Drug Application for Zilretta – its extended-release steroid injection. The Burlington, Mass.-based company won Fast Track...
View ArticleClik here to view.
Owlstone Medical launches 1,400-patient study for colon cancer ‘breathalyzer’
Owlstone Medical said today it is launching a 1,400-patient clinical trial of its breath-based colorectal cancer diagnostic technology. The Intercept trial aims to explore the accuracy of the...
View ArticleClik here to view.
Acelity pays down debt with LifeCell proceeds, snags new $1.1B facility
Acelity said today it used proceeds from the sale of its LifeCell regenerative medicine to repay debt owed by the company and its subsidiaries Kinetic Concepts and KCI USA. The San Antonio, Texas-based...
View ArticleClik here to view.
Brazilian regulators drop medical device fees
By Stewart Eisenhart, Emergo Group Brazilian medical device market regulators plan to officially reduce registration and quality inspection fees for medical device companies after the country’s...
View ArticleClik here to view.
Sens. Sanders, Cruz talk drug pricing, Obamacare in town hall debate
Sens. Bernie Sanders (I-Vermont) and Ted Cruz (R-Texas) met last night to debate the future of Obamacare in a town-hall debate. The 2 senators are opposed on how to provide health care coverage to...
View Article
